DermaSensor
DermaSensor raises $16M Series B at $85M valuation
Quick Facts
DermaSensor: Series B Funding Round
DermaSensor has successfully raised $16M in Series B funding, reaching a valuation of $85M.
Company Overview
AI-powered skin cancer screening device for early detection
Funding Details
The Series B round was led by Healthtech Capital, with participation from LSP.
Company Information
- Headquarters: Miami, FL
- Founded: 2020
- Employees: 70+
- Category: HealthTech
Investment
DermaSensor plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Healthtech Capital: Verified investor in Series B
- LSP: Verified investor in Series B
Key Investors
About the Author
Related Company Reports
AccelerateStack Platform raises $75M Series C at $226M valuation
AccelerateStack Platform secures $75M in Series C funding led by Intel Capital, reaching $226M valuation as it accelerates growth in the healthtech sector.
Devoted Health Partners Headquarters - Office Location & Address
Discover Devoted Health Partners's headquarters at 100 2nd Ave, Waltham, MA 02451. Medicare Advantage insurance. Learn about the office facilities and work environment.
Invitae Headquarters - Office Location & Address
Discover Invitae's headquarters at 1400 16th St, San Francisco, CA 94103. Medical genetic testing. Learn about the office facilities and work environment.